Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant
Standard
Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant : a center's experience. / Sotiropoulos, G C; Lang, H; Saner, F H; Beckebaum, S; Wandelt, M; Molmenti, E P; Nadalin, S; Treckmann, J; Bockhorn, M; Fouzas, I; Malagó, M; Gerken, G; Broelsch, C E; Paul, A.
in: TRANSPL P, Jahrgang 40, Nr. 9, 01.11.2008, S. 3196-7.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant
T2 - a center's experience
AU - Sotiropoulos, G C
AU - Lang, H
AU - Saner, F H
AU - Beckebaum, S
AU - Wandelt, M
AU - Molmenti, E P
AU - Nadalin, S
AU - Treckmann, J
AU - Bockhorn, M
AU - Fouzas, I
AU - Malagó, M
AU - Gerken, G
AU - Broelsch, C E
AU - Paul, A
PY - 2008/11/1
Y1 - 2008/11/1
N2 - BACKGROUND: Orthotopic liver transplantation (OLT) represents the only curative treatment for end-stage liver disease, but its application is limited because of organ shortages. The purpose of this study was to review the long-term outcomes after OLT during a 2-year period of 45 rescue offers organs within Eurotransplant.PATIENTS AND METHODS: Forty-five deceased donor liver allografts had been officially offered to and rejected by other transplantation centers 162 times prior to our acceptance. Data analysis addressed recurrence of primary disease, ischemic-type biliary lesions (ITBL), re-evaluation or relisting for OLT, re-OLT, as well as overall patient and graft survivals.RESULTS: Six patients underwent retransplantation because of primary nonfunction (n = 4), hepatitis C recurrence (n = 1), and secondary biliary cirrhosis following ITBL (n = 1). Five additional patients developed ITBL and received endoscopic treatment. Currently, 34 patients are alive after a median follow-up of 44.5 months. Median graft survival is 43.2 months. Patient versus patient/first graft survival at 1, 3, and 5 years is 82%, 78%, and 74%, versus 76%, 69%, and 65%, respectively.CONCLUSIONS: OLT with rescue organs is a reasonable policy, with acceptable long-term patient/graft survivals, providing a real expansion of the donor pool.
AB - BACKGROUND: Orthotopic liver transplantation (OLT) represents the only curative treatment for end-stage liver disease, but its application is limited because of organ shortages. The purpose of this study was to review the long-term outcomes after OLT during a 2-year period of 45 rescue offers organs within Eurotransplant.PATIENTS AND METHODS: Forty-five deceased donor liver allografts had been officially offered to and rejected by other transplantation centers 162 times prior to our acceptance. Data analysis addressed recurrence of primary disease, ischemic-type biliary lesions (ITBL), re-evaluation or relisting for OLT, re-OLT, as well as overall patient and graft survivals.RESULTS: Six patients underwent retransplantation because of primary nonfunction (n = 4), hepatitis C recurrence (n = 1), and secondary biliary cirrhosis following ITBL (n = 1). Five additional patients developed ITBL and received endoscopic treatment. Currently, 34 patients are alive after a median follow-up of 44.5 months. Median graft survival is 43.2 months. Patient versus patient/first graft survival at 1, 3, and 5 years is 82%, 78%, and 74%, versus 76%, 69%, and 65%, respectively.CONCLUSIONS: OLT with rescue organs is a reasonable policy, with acceptable long-term patient/graft survivals, providing a real expansion of the donor pool.
KW - Adult
KW - Cadaver
KW - Female
KW - Graft Survival
KW - Humans
KW - Liver Failure
KW - Liver Transplantation
KW - Male
KW - Middle Aged
KW - Patient Selection
KW - Reoperation
KW - Survival Rate
KW - Survivors
KW - Tissue Donors
KW - Transplantation, Homologous
KW - Treatment Outcome
U2 - 10.1016/j.transproceed.2008.08.055
DO - 10.1016/j.transproceed.2008.08.055
M3 - SCORING: Journal article
C2 - 19010232
VL - 40
SP - 3196
EP - 3197
JO - TRANSPL P
JF - TRANSPL P
SN - 0041-1345
IS - 9
ER -